Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals

NeuroRx

Volumn 2, Issue 2, 2005, Pages 250-264

  Pirko, Istvan ^a   Fricke, Stanley Thomas ^b   Johnson, Aaron J ^a   Rodriguez, Moses ^c   Macura, Slobodan I ^d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Mayo Clinic   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

And phosphorous MRS; Microscopic resolution MRI; MR microscopy; MR spectroscopy; Proton; Small animal MRI

Indexed keywords

CENTRAL NERVOUS SYSTEM; CLINICAL PRACTICE; EXPERIMENTAL ANIMAL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE ANGIOGRAPHY; MICROSCOPY; MOLECULAR IMAGING; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SIGNAL NOISE RATIO; SPECTROSCOPY;

EID: 16344363426     PISSN: 15455343     EISSN: 15455351     Source Type: Journal    
DOI: 10.1602/neurorx.2.2.250     Document Type: Article

References (84)

1. Hansen G, Crooks LE, Davis P, De Groot J, Herfkens R, Margulis AR, et al. In vivo imaging of the rat anatomy with nuclear magnetic resonance. Radiology 136:695-700, 1980.
2. Bammer R, Skare S, Newbould R, Liu C, Thijs V, Ropele S, Clayton DB, Krueger G, Moseley ME, Glover GH. Foundations of advanced magnetic resonance imaging. NeuroRx 2:167-196, 2005.
3. Lin A, Ross BD, Harris K, Wong W. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making. NeuroRx 2:197-214, 2005.
4. Brooks DJ. Positron emission tomography and single-photon emission computed tomography in central nervous system drug development. NeuroRx 2:226-236, 2005.
5. Devous MD Sr. Single-photon emission computed tomography in neurotherapeutics. NeuroRx 2:237-249, 2005.
6. Robb RA. The virtualization of medicine: a decade of pitfalls and progress. Stud Health Technol Inform 85:1-7, 2002.
7. Robb RA. 3-D visualization in biomedical applications. Annu Rev Biomed Eng 1:377-399, 1999.
8. Turner R, Howseman A, Rees GE, Josephs O, Friston K. Functional magnetic resonance imaging of the human brain: data acquisition and analysis. Exp Brain Res 123:5-12, 1998.
9. Lukasik VM, Gillies RJ. Animal anaesthesia for in vivo magnetic resonance. NMR Biomed 16:459-467, 2003.
10. Kannurpatti SS, Biswal BB. Effect of anesthesia on CBF, MAP and fMRI-BOLD signal in response to apnea. Brain Res 1011:141-147, 2004.
11. Fricke ST, Vink R, Chiodo C, Cernak I, Ileva L, Faden AI. Consistent and reproducible slice selection in rodent brain using a novel stereotaxic device for MRI. J Neurosci Methods 136:99-102, 2004.
12. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Magnetic resonance imaging: Physical principles and sequence design. Ed 1. Canada: Wiley-Liss, 1999.
13. McRobbie DW, Moore EA, Graves MJ, Prince MR. MRI: from picture to protons. Cambridge, UK: Cambridge University Press, 2002.
14. Liang Z-P, Lauterbur PC. Principles of magnetic resonance imaging: a signal processing perspective. Ed 1. Piscataway, NJ: Wiley-IEEE Press, 1999.
15. Kumar A, Welti D, Ernst RR. NMR Fourier zeugmatography. J Magn Reson 18:69-83, 1975.
16. Ernst RR. Nobel Lecture. Nuclear magnetic resonance Fourier transform spectroscopy. Biosci Rep 12:143-187, 1992.
17. Back PJ, Coy A, Xia Y, Callaghan PT, Diamante LM, Umbach SL. Some biophysical applications of motional contrast in n.m.r. microscopy. Int J Biol Macromol 13:181-189, 1991.
18. Callaghan PT, Clark CJ, Forde LC. Use of static and dynamic NMR microscopy to investigate the origins of contrast in images of biological tissues. Biophys Chem 50:225-235, 1994.
19. Yang QX, Williams GD, Demeure RJ, Mosher TJ, Smith MB. Removal of local field gradient artifacts in T2*-weighted images at high fields by gradient-echo slice excitation profile imaging. Magn Reson Med 39:402-409, 1998.
20. Yang QX, Demeure RJ, Dardzinski BJ, Arnold BW, Smith MB. Multiple echo frequency-domain image contrast: improved signal-to-noise ratio and T2 (T2*) weighting. Magn Reson Med 41:423-428, 1999.
21. Ordidge RJ, Gorell JM, Deniau JC, Knight RA, Helpern JA. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 32:335-341, 1994.
22. Frahm J, Merboldt KD, Hanicke W. Direct FLASH MR imaging of magnetic field inhomogeneities by gradient compensation. Magn Reson Med 6:474-480, 1988.
23. Hennig J, Friedburg H. Clinical applications and methodological developments of the RARE technique. Magn Reson Imaging 6:391-395, 1988.
24. Jacobs RE, Papan C, Ruffins S, Tyszka JM, Fraser SE. MRI: volumetric imaging for vital imaging and atlas construction. Nat Rev Mol Cell Biol Suppl:S10-S16, 2003.
25. Dhenain M, Ruffins SW, Jacobs RE. Three-dimensional digital mouse atlas using high-resolution MRI. Dev Biol 232:458-470, 2001.
26. MacKenzie-Graham A, Lee EF, Dinov ID, Bota M, Shattuck DW, Ruffins S et al. A multimodal, multidimensional atlas of the C57BL/6J mouse brain. J Anat 204:93-102, 2004.
27. Kovacevic N, Henderson JT, Chan E, Lifshitz N, Bishop J, Evans AC, et al. A three-dimensional MRI atlas of the mouse brain with estimates of the average and variability. Cereb Cortex, September 1, 2004.
28. Jacobs RE, Ahrens ET, Dickinson ME, Laidlaw D. Towards a microMRI atlas of mouse development. Comput Med Imaging Graph 23:15-24, 1999.
29. Pautler RG, Mongeau R, Jacobs RE. In vivo trans-synaptic tract tracing from the murine striatum and amygdala utilizing manganese enhanced MRI (MEMRI). Magn Reson Med 50:33-39, 2003.
30. Pautler RG, Koretsky AP. Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. NeuroImage 16:441-448, 2002.
31. Hu TC, Pautler RG, MacGowan GA, Koretsky AP. Manganese-enhanced MRI of mouse heart during changes in inotropy. Magn Reson Med 46:884-890, 2001.
32. Pautler RG, Silva AC, Koretsky AP. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med 40:740-748, 1998.
33. Malisza KL, Stroman PW. Functional imaging of the rat cervical spinal cord. J Magn Reson Imaging 16:553-558, 2002.
34. Malisza KL, Stroman PW, Turner A, Gregorash L, Foniok T, Wright A. Functional MRI of the rat lumbar spinal cord involving painful stimulation and the effect of peripheral joint mobilization. J Magn Reson Imaging 18:152-159, 2003.
35. Bock C, Schmitz B, Kerskens CM, Gyngell ML, Hossmann KA, Hoehn-Berlage M. Functional MRI of somatosensory activation in rat: effect of hypercapnic up-regulation on perfusion- and BOLD-imaging. Magn Reson Med 39:457-461, 1998.
36. Mandeville JB, Marota JJ, Kosofsky BE, Keltner JR, Weissleder R, Rosen BR et al. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med 39:615-624, 1998.
37. Brinker G, Bock C, Busch E, Krep H, Hossmann KA, Hoehn-Berlage M. Simultaneous recording of evoked potentials and T2*-weighted MR images during somatosensory stimulation of rat. Magn Reson Med 41:469-473, 1999.
38. Wu EX, Wong KK, Andrassy M, Tang H. High-resolution in vivo CBV mapping with MRI in wild-type mice. Magn Reson Med 49:765-770, 2003.
39. Bakshi R, Minagar A, Jaisani Z, Wolinsky JS. Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx 2:277-303.
40. Pirko I, Gamez J, Johnson AJ, Macura SI, Rodriguez M. Dynamics of MRI lesion development in an animal model of viral-induced acute progressive CNS demyelination. Neuroimage 21:576-582, 2004.
41. Pirko I, Johnson A, Gamez J, Macura SI, Rodriguez M. Disappearing "TI black holes" in an animal model of multiple sclerosis. Front Biosci 9:1222-1227, 2004.
42. Heide AC, Richards TL, Alvord EC Jr, Peterson J, Rose LM. Diffusion imaging of experimental allergic encephalomyelitis. Magn Reson Med 29:478-484, 1993.
43. Ahrens ET, Laidlaw DH, Readhead C, Brosnan CF, Fraser SE, Jacobs RE. MR microscopy of transgenic mice that spontaneously acquire experimental allergic encephalomyelitis. Magn Reson Med 40:119-132, 1998.
44. Schwarcz A, Natt O, Watanabe T, Boretius S, Frahm J, Michaelis T. Localized proton MRS of cerebral metabolite profiles in different mouse strains. Magn Reson Med 49:822-827, 2003.
45. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484-499, 2004.
46. Bulte JW, Arbab AS, Douglas T, Frank JA. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Methods Enzymol 386:275-299, 2004.
47. Bulte JW, Ben-Hur T, Miller BR, Mizrachi-Kol R, Einstein O, Reinhartz E, et al. MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain. Magn Reson Med 50:201-205, 2003.
48. Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, et al. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 55:654-659, 2004.
49. Pirko I, Ciric B, Gamez J, Bieber AJ, Warrington AE, Johnson AJ, et al. A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. FASEB J 18:1577-1579,2004.
50. Pirko I, Ciric B, Johnson AJ, Gamez J, Rodriguez M, Macura S. Magnetic resonance imaging of immune cells in inflammation of central nervous system. Croat Med J 44:463-468, 2003.
51. Pirko I, Johnson A, Ciric B, Gamez J, Macura SI, Pease LR, et al. In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies. FASEB J 18:179-182, 2004.
52. Lee WT, Chang C. Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease. Prog Neurobiol 72:87-110, 2004.
53. Choi IY, Lee SP, Guilfoyle DN, Helpern JA. In vivo NMR studies of neurodegenerative diseases in transgenic and rodent models. Neurochem Res 28:987-1001, 2003.
54. Gilissen EP, Ghosh P, Jacobs RE, Allman JM. Topographical localization of iron in brains of the aged fat-tailed dwarf lemur (Cheirogaleus medius) and gray lesser mouse lemur (Microcebus murinus). Am J Primatol 45:291-299, 1998.
55. McDaniel B, Sheng H, Warner DS, Hedlund LW, Benveniste H. Tracking brain volume changes in C57BL/6J and ApoE-deficient mice in a model of neurodegeneration: a 5-week longitudinal micro-MRI study. Neuroimage 14:1244-1255, 2001.
56. Poduslo JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, et al. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis 11:315-329, 2002.
57. Poduslo JF, Curran GL, Peterson JA, McCormick DJ, Fauq AH, Khan MA, et al. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques. Biochemistry 43:6064-6075, 2004.
58. Zhang J, Yarowsky P, Gordon MN, Di Carlo G, Munireddy S, van Zijl PC, et al. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging. Magn Reson Med 51:452-457, 2004.
59. Jack CR Jr, Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, et al. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 52:1263-1271, 2004.
60. Dedeoglu A, Choi JK, Cormier K, Kowall NW, Jenkins BG. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Res 1012:60-65, 2004.
61. Andjus RK, D'akula A, Markley JL, Macura S. Brain energetics and tolerance to anoxia in deep hypothermia. Ann NY Acad Sci, in press.
62. Hesselbarth D, Franke C, Hata R, Brinker G, Hoehn-Berlage M. High resolution MRI and MRS: a feasibility study for the investigation of focal cerebral ischemia in mice. NMR Biomed 11:423-429, 1998.
63. Hoehn M, Nicolay K, Franke C, van der Sanden B. Application of magnetic resonance to animal models of cerebral ischemia. J Magn Reson Imaging 14:491-509, 2001.
64. Hata R, Mies G, Wiessner C, Fritze K, Hesselbarth D, Brinker G, et al. A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 18:367-375, 1998.
65. Xue R, van Zijl PC, Crain BJ, Solaiyappan M, Mori S. In vivo three-dimensional reconstruction of rat brain axonal projections by diffusion tensor imaging. Magn Reson Med 42:1123-1127, 1999.
66. Dreher W, Kuhn B, Gyngell ML, Busch E, Niendorf T, Hossmann KA, et al. Temporal and regional changes during focal ischemia in rat brain studied by proton spectroscopic imaging and quantitative diffusion NMR imaging. Magn Reson Med 39:878-888, 1998.
67. Malisza KL, Kozlowski P, Ning G, Bascaramurty S, Tuor UI. Metabolite changes in neonatal rat brain during and after cerebral hypoxia-ischemia: A magnetic resonance spectroscopic imaging study. NMR Biomed 12:31-38, 1999.
68. Beckmann N. High resolution magnetic resonance angiography non-invasively reveals mouse strain differences in the cerebrovascular anatomy in vivo. Magn Reson Med 44:252-258, 2000.
69. Goetz P, Blamire A, Rajagopalan B, Cadoux-Hudson T, Young D, Styles P. Increase in apparent diffusion coefficient in normal appearing white matter following human traumatic brain injury correlates with injury severity. J Neurotrauma 21:645-654, 2004.
70. Stoffel M, Blau C, Reinl H, Breidt J, Gersonde K, Baethmann A, et al. Identification of brain tissue necrosis by MRI: validation by histomorphometry. J Neurotrauma 21:733-740, 2004.
71. Schuhmann MU, Stiller D, Skardelly M, Bernarding J, Klinge PM, Samii A et al. Metabolic changes in the vicinity of brain contusions: a proton magnetic resonance spectroscopy and histology study. J Neurotrauma 20:725-743, 2003.
72. Schuhmann MU, Stiller D, Skardelly M, Thomas S, Samii M, Brinker T. Long-time in-vivo metabolic monitoring following experimental brain contusion using proton magnetic resonance spectroscopy. Acta Neurochir Suppl 81:209-212, 2002.
73. Phuong LK, Allen C, Peng KW, Giannini C, Greiner S, TenEyck CJ, et al. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res 63:2462-2469, 2003.
74. Hirakawa K, Naruse S, Higuchi T, Horikawa Y, Tanaka C, Ebisu T. The investigation of experimental brain tumours using SIP-MRS and 1H-MRI. Acta Neurochir Suppl (Wien) 43:140-144, 1988.
75. Gyngell ML, Els T, Hoehn-Berlage M, Hossmann KA. Proton MR spectroscopy of experimental brain tumors in vivo. Acta Neurochir Suppl (Wien) 60:350-352, 1994.
76. Howe FA, Robinson SP, Rodrigues LM, Stubbs M, Griffiths JR. Issues in GRE & SE magnetic resonance imaging to probe tumor oxygenation. Adv Exp Med Biol 530:441-448, 2003.
77. Howe FA, Robinson SP, McIntyre DJ, Stubbs M, Griffiths JR. Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR Biomed 14:497-506, 2001.
78. Fricke S, Galloway M, Seraji-Bozorgzad N, Mitchell T, Posse S, More G. Ex-vivo neurochemical kinetics in brain tissue specimens monitored via quantative in-vivo MRS of the mouse brain. Paper presented at the conference of the International Society for Magnetic Resonance in Medicine, Honolulu, HI, p 159, 2002.
79. Pfeuffer J, Tkac I, Provencher SW, Gruetter R. Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. J Magn Reson 141:104-120, 1999.
80. Lenkinski RE, Holland GA, Allman T, Vogele K, Kressel HY, Grossman RI, et al. Integrated MR imaging and spectroscopy with chemical shift imaging of P-31 at 1.5 T: initial clinical experience. Radiology 169:201-206, 1988.
81. Pykett IL, Rosen BR. Nuclear magnetic resonance: in vivo proton chemical shift imaging. Work in progress. Radiology 149:197-201, 1983.
82. Barton SJ, Howe FA, Tomlins AM, Cudlip SA, Nicholson JK, Bell BA et al. Comparison of in vivo 1H MRS of human brain tumours with IH HR-MAS spectroscopy of intact biopsy samples in vitro. Magma 8:121-128, 1999.
83. Kamezawa T, Asakura T, Yatsushiro K, Niiro M, Kasamo S, Fujimoto T. 31P-magnetic resonance spectroscopic study on the effect of glycerol on cold-induced brain edema. Acta Neurochir Suppl (Wien) 60:499-501, 1994.
84. Giannini C, Sarkaria J, Saito A, Uhm J, Galanis E, Carlson B, et al. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of GBM. Neuro-Oncology, in press.